A carregar...
Safety of apixaban for venous thromboembolism prophylaxis: the evidence to date
Apixaban, a direct orally active anticoagulant (selective, direct factor Xa inhibitor) is approved for (primary) prevention of venous thromboembolism (VTE) in patients undergoing elective total-hip or total-knee arthroplasty, for acute treatment/prevention of recurrent events in patients with VTE, a...
Na minha lista:
| Publicado no: | Drug Healthc Patient Saf |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4762581/ https://ncbi.nlm.nih.gov/pubmed/26937206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S74410 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|